Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Amisha Patel

Physician Assistant, Medical Baton Rouge, LA Physician Assistant

NPI 1508262437 CMS profile 11062978

9118 Bluebonnet Centre Blvd, Baton Rouge, LA 70809

Open in the dashboard

General payments

$3,595

207 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amisha Patel of Baton Rouge, LA is reported in the CMS Open Payments database as having received $3,595 across 207 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $862 41
2024 General $1,022 56
2023 General $613 38
2022 General $529 33
2021 General $569 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amisha Patel
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Amisha Patel were reported at $862. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Amisha Patel Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $569 $156 $41–$563 $132
2022 $529 $185 $55–$649 $149
2023 $613 $199 $58–$717 $160
2024 $1,022 $206 $62–$740 $164
2025 $862 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Collegium Pharmaceutical, Inc. $954 49 payments
  2. Valinor Pharma, LLC $949 58 payments
  3. Pfizer Inc. $352 25 payments
  4. Scilex Pharmaceuticals Inc. $255 12 payments
  5. Salix Pharmaceuticals, a division of Bausch Health US, LLC $213 11 payments
  6. Biohaven Pharmaceutical Holding Company Ltd. $179 15 payments
  7. Biohaven Pharmaceuticals, Inc. $170 16 payments
  8. BIOTRONIK NRO, Inc. $112 3 payments
  9. Saluda Medical Americas, Inc. $88 1 payment
  10. AbbVie, Inc. $62 4 payments
  11. Other $261 13 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,580 205 payments
  2. Education $15 2 payments
Products named General payments · program years 2021–2025
  1. MOVANTIK Gastroenterology $748 44 payments
  2. BELBUCA $676 34 payments
  3. NURTEC ODT Pain $352 25 payments
  4. NURTEC ODT Primary Care $349 31 payments
  5. XTAMPZA $278 15 payments
  6. ZTLido $214 10 payments
  7. ZAVZPRET $204 13 payments
  8. MOVANTIK Pain Management $201 14 payments
  9. RELISTOR $115 6 payments
  10. Prospera $112 3 payments
  11. Other $434 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

207 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record